Ming capital
VC Fund
Shenzhen, China
Ming capital is a Shenzhen (China) originated global healthcare venture capital firm.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 30%
Last updated:
For AI agents: llms.txt
Industries Ming capital invests in
Stages Ming capital invests in
Countries Ming capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ofer Hornick
|
|||
4 more contacts available
Investment Focus
Industry
- Health Care 3 (30%)
- Medical Device 3 (30%)
- Medical 2 (20%)
- Biotechnology 2 (20%)
- Health Diagnostics 2 (20%)
Stage
- Seed 2 (20%)
- Series A 2 (20%)
- Series B 2 (20%)
- Angel 1 (10%)
- Series C 1 (10%)
Country
- China 6 (60%)
- United States 2 (20%)
- Belgium 1 (10%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Ofer Hornick
Chief Medical Scientist
|
Chief Medical Scientist | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Pangbot
|
PangBot is a firm that specializes in the development of intelligent table tennis serving robots. | $29.3M / Series A / Apr 14, 2026 | |
AlloyX
|
AlloyX makes it simple and accessible for protocols, DAOs, and institutional investors to create diversified RWA investment strategies. We provide lenders with a flexible and efficient platform for managing all of their RWA assets based on their yield, risk, and liquidity preferences. | $10M / Seed / Dec 30, 2024 | |
Svision
|
Svision is a healthcare start-up that develops and produces high-end ophthalmic imaging equipment. | $43.1M / Series C / Mar 09, 2023 | |
Binhui Biotech
|
Wuhan Binhui Biotechnology Co., Ltd. was established in 2010. The company is located in the Optics Valley Bio City of Donghu National Independent Innovation Demonstration Zone. The company is committed to providing innovative products and services for the field of oncology integration (including diagnosis and treatment), and developing products andservices that have independent intellectual property rights and can compete with other manufacturers on the international stage. | $46.9M / Series B / Apr 19, 2022 | |
Gene Vector
|
Chengdu Genevector Biotechnology Co., Ltd. (Genevector, Genevector) is a biotechnology company engaged in the research and development of new drugs for adeno-associated virus (AAV) gene therapy. The company is committed to the development of new AAV gene therapy drugs for ophthalmic diseases, neuromuscular diseases, genetic and metabolic diseases,etc. | $3.2M / Seed / Mar 10, 2022 | |
Lingtan Intelligent Technology
|
Lingtan Intelligent Technology focuses on the development of innovative and sustainable distributed energy storage products and services, focusing on the research and development of energy storage system hardware, software and virtual power plant trading platforms, and is committed to providing factories, commercial buildings, charging stations,data Industrial and commercial markets such as hubs offer energy storage-based solutions. | Angel / Jan 11, 2022 | |
CareTaker Medical
|
CareTaker is the worlds most innovative patient monitor Using only a simple finger cuff to measure Continuous Beat-by-Beat Blood Pressure (“cNIBP”), Heart Rate, and other physiological parameters enabling safe, secure, and accurate remote patient monitoring via their secure Android App, HIPPA-compliant Cloud Portals, or interfaced with otherpatient monitoring systems.CareTaker sets a new standard in mobility, simplicity, and cost, enabling continuous realtime monitoring as patients traverse the full continuum of care, within the hospital, during transport, and after discharge. | Series B / Jun 02, 2020 | |
Miracor Medical
|
Miracor Medical operates as a medical device company. It develops and commercializes a pressure-controlled intermittent coronary sinus occlusion (PiCSO) impulse system for cardiac surgeons to facilitate the PiCSO treatment for myocardial infarction/heart attack patients undergoing coronary artery bypass grafting surgery. Miracor Medicaloffers a therapy for improving micro-vascular perfusion functions through the coronary sinus. Werner Mohl founded it in 2008, with its headquarters in Awans in Belgium. | $5.5M / Series D / Sep 04, 2018 | |
|
Miracor Medical
|
Miracor Medical operates as a medical device company. It develops and commercializes a pressure-controlled intermittent coronary sinus occlusion (PiCSO) impulse system for cardiac surgeons to facilitate the PiCSO treatment for myocardial infarction/heart attack patients undergoing coronary artery bypass grafting surgery. Miracor Medicaloffers a therapy for improving micro-vascular perfusion functions through the coronary sinus. Werner Mohl founded it in 2008, with its headquarters in Awans in Belgium. | $27.4M / Series D / Jan 04, 2018 | |
0glass
|
0glass is the first high-tech company to apply Ar-smart glasses to industry and training, focusing on smart glasses and enhancing the core technology and product development. It is the provider of AR intelligent eyewear industry solutions.0glass has the independent intellectual property rights of industrial applications such as accurateidentification of images, enhance the reality of advanced technology, to become the industry's most natural human-computer interaction services, mining the most deep value of the data of artificial intelligence company. And intelligent devices, Internet of Things and cloud computing and other deep integration, to create a combination of hardware and software platform to enhance the reality of products and services | $1.4M / Series A / May 18, 2017 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Ming capital invest in?
Ming capital invests primarily in Health Care, Medical Device and Medical startups, most often at Seed and Series A stage. Most of the 10 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Ming capital?
Public channels for Ming capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Ming capital?
The team at Ming capital includes Ofer Hornick (Chief Medical Scientist). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
